| First Author | Henshall TL | Year | 2017 |
| Journal | Cell Death Differ | Volume | 24 |
| Issue | 12 | Pages | 2150-2160 |
| PubMed ID | 28862701 | Mgi Jnum | J:258636 |
| Mgi Id | MGI:6142511 | Doi | 10.1038/cdd.2017.137 |
| Citation | Henshall TL, et al. (2017) Deletion of Nedd4-2 results in progressive kidney disease in mice. Cell Death Differ 24(12):2150-2160 |
| abstractText | NEDD4-2 (NEDD4L), a ubiquitin protein ligase of the Nedd4 family, is a key regulator of cell surface expression and activity of the amiloride-sensitive epithelial Na(+) channel (ENaC). While hypomorphic alleles of Nedd4-2 in mice show salt-sensitive hypertension, complete knockout results in pulmonary distress and perinatal lethality due to increased cell surface levels of ENaC. We now show that Nedd4-2 deficiency in mice also results in an unexpected progressive kidney injury phenotype associated with elevated ENaC and Na(+)Cl(-) cotransporter expression, increased Na(+) reabsorption, hypertension and markedly reduced levels of aldosterone. The observed nephropathy is characterized by fibrosis, tubule epithelial cell apoptosis, dilated/cystic tubules, elevated expression of kidney injury markers and immune cell infiltration, characteristics reminiscent of human chronic kidney disease. Importantly, we demonstrate that the extent of kidney injury can be partially therapeutically ameliorated in mice with nephron-specific deletions of Nedd4-2 by blocking ENaC with amiloride. These results suggest that increased Na(+) reabsorption via ENaC causes kidney injury and establish a novel role of NEDD4-2 in preventing Na(+)-induced nephropathy. Contrary to some recent reports, our data also indicate that ENaC is the primary in vivo target of NEDD4-2 and that Nedd4-2 deletion is associated with hypertension on a normal Na(+) diet. These findings provide further insight into the critical function of NEDD4-2 in renal pathophysiology. |
